Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

2009 H1N1 influenza virus infection and necrotizing pneumonia treated with extracorporeal membrane oxygenation

  • Ji, Sun-Tae (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Ok-Jeong (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Ji-Hyuk (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Ahn, Kang-Mo (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Cho, Joong-Bum (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jeong, Soo-In (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Han, Woo-Sik (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Yae-Jean (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2010.09.10
  • 심사 : 2011.01.03
  • 발행 : 2011.08.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

A 3-year-old girl with acute respiratory distress syndrome due to a H1N1 2009 influenza virus infection was complicated by necrotizing pneumonia was successfully treated with extracorporeal membrane oxygenation (ECMO). This is the first reported case in which a pediatric patient was rescued with ECMO during the H1N1 influenza epidemic in Korea in 2009.

키워드

참고문헌

  1. World Health Organization. Influenza-like illness in the United States and Mexico [Internet]. Geneva: World Health Organization; c2011 [cited 2010 Feb 13]. Available from: http://www.who.int/csr/don/2009_04_24/ en/index.html.
  2. World Health Organization. Pandemic (H1N1) 2009 - update 88 [Internet]. Geneva: World Health Organization; c2011 [cited 2010 Mar 21]. Available from: http://www.who.int/csr/don/2010_02_19/en/index. html.
  3. Korea Centers for Disease Control and Prevention. Characteristics of survival Versus death related Influenza A(H1N1) 2009 in Korea [Internet]. Cheongwon (KR): Korea Centers for Disease Control and Prevention; c2011 [cited 2010 Oct 17]. Available from: http://www.cdc.go.kr/ contents/information/had/b/10737_view.html.
  4. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302:1872-9. https://doi.org/10.1001/jama.2009.1496
  5. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, Beca J, Bellomo R, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009;302:1888-95. https://doi.org/10.1001/jama.2009.1535
  6. ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-34. https://doi.org/10.1056/NEJMoa0908481
  7. Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 - update. Wkly Epidemiol Rec 2009;84:305-8.
  8. Hui DS, Lee N, Chan PK. Clinical management of pandemic 2009 influenza A(H1N1) infection. Chest 2010;137:916-25.. https://doi.org/10.1378/chest.09-2344
  9. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009;302:1896-902. https://doi.org/10.1001/jama.2009.1583
  10. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009;84:185-9.
  11. Freed DH, Henzler D, White CW, Fowler R, Zarychanski R, Hutchison J, et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth 2010;57:240-7. https://doi.org/10.1007/s12630-009-9253-0
  12. The Korean Society of Critical Care Medicine. Management protocol for new H1N1 influenza pneumonia (including suspicious case) with respiratory failure [Internet]. Seoul: Korean Society of Critical Care Medicine; c2008 [cited 2010 Mar 24]. Available from: http://ksccm.org/ flu/flu03.html.
  13. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351-63. https://doi.org/10.1016/S0140-6736(09)61069-2
  14. Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007;13:97-103. https://doi.org/10.3201/eid1301.060716
  15. Frenckner B, Radell P. Respiratory failure and extracorporeal membrane oxygenation. Semin Pediatr Surg 2008;17:34-41. https://doi.org/10.1053/j.sempedsurg.2007.10.006
  16. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009;58:1071-4.
  17. Goel N, Chaudhary U, Aggarwal R, Bala K. Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the Intensive care unit. Indian J Crit Care Med 2009;13:148-51. https://doi.org/10.4103/0972-5229.58540

피인용 문헌

  1. Severe Influenza Treatment Guideline vol.86, pp.1, 2011, https://doi.org/10.3904/kjm.2014.86.1.116
  2. Severe influenza treatment guideline vol.29, pp.1, 2011, https://doi.org/10.3904/kjim.2014.29.1.132
  3. Outcomes of Extracorporeal Membrane Oxygenation in Children: An 11-Year Single-Center Experience in Korea vol.50, pp.5, 2011, https://doi.org/10.5090/kjtcs.2017.50.5.317